Alvotech (LS:A3DK8U) Financings

Alvotech

Financings

RaiseDateIn US dollars
Public offering of ordinary shares
Closed: US$98M raised · US$3.75 a share · BofA Securities +2
Dealers: BofA Securities (co-lead), Jefferies (co-lead), Evercore ISI (co-lead)
Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes
Jun 18, 2026
Private placement of ordinary shares
Announced: about US$67M · US$3.75 a share
Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes
Jun 18, 2026
Senior unsecured convertible bonds due 2030
Made bigger: US$108M · DNB Carnegie
Dealers: DNB Carnegie (lead)
Use of proceeds: Continued investment in the R&D pipeline, scaling up production and global product launches.
Dec 17, 2025
Private placement of sDRs and ordinary shares
Closed: DNB Carnegie Investment Bank AB (publ) +3
Dealers: DNB Carnegie Investment Bank AB (publ) (co-lead), Citigroup Global Markets Limited (co-lead), Skandinaviska Enskilda Banken AB (publ) (co-lead), ACRO Securities HF (co-lead)
Use of proceeds: Accelerate R&D activities, especially in Sweden after the Xbrane R&D acquisition, expand pipeline, and general corporate purposes
Jun 11, 2025
Public offering of swedish Depository Receipts (SDRs)
Update: about SEK 39M · SEK 87.51 a receipt · DNB Markets, a part of DNB Bank ASA, Sweden Branch +2
Dealers: DNB Markets, a part of DNB Bank ASA, Sweden Branch, Carnegie Investment Bank, DNB Carnegie Investment Bank AB (publ)
May 19, 2025US$3.99M

Read by 6ix AI from the company's releases